Patients can be infected again and again, but research could lead to first successful vaccine for superbug MRSA and other staph bacteria
For years, medical investigators have tried and failed to develop vaccines for a type of staph bacteria associated with the deadly superbug MRSA. But a new study by Cedars-Sinai investigators shows how staph cells evade the body's immune system, offering a clearer picture of how a successful vaccine would work.
Staph frequently causes skin infections but occasionally can lead to deadly conditions such as sepsis, pneumonia and bloodstream infections, particularly in hospitalized patients whose immune systems could be weakened by illness.
One strain of the bacterium, the superbug methicillin-resistant Staphylococcus aureus (MRSA), is considered one of the top drug-resistant threats in the U.S., causing more than 11,000 deaths per year, according to the Centers for Disease Control and Prevention. In fact, the superbug kills more Americans than HIV.
"Widespread MRSA infections have prompted routine use of once last-line antibiotics, and this is making the antibiotic resistance problem worse," said George Liu, MD, PhD, co-lead author of the study and a pediatric infectious diseases physician at Cedars-Sinai's Maxine Dunitz Children's Health Center and the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute. "Our study focuses on why MRSA is so common and why we never develop immunity to these bacteria."
The study, published in the peer-reviewed journal Cell Host & Microbe, also sheds light on how investigators could develop an effective vaccine against staph.
When exposed to a pathogen like a staph bacterium, the body usually fights it and then forms a memory of how its immune system responded. The next time the body encounters the same pathogen, it can use that memory to fight off the microbe much more easily.
But the body can suffer from repeated staph infections throughout life without developing a robust protective memory immune response. The study shows that staph bacteria are able to dodge this immune response.
When the staph cell wall primarily is kept intact after infecting a host, bacterial molecules don't escape the staph cell and the body isn't prompted to produce robust protective immune memory.
"Essentially, staph tricks the body's T cells, which are white blood cells that fight infection, and prevents them from mounting an effective defense," said co-lead author Gislaine Martins, PhD, an assistant professor at the F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute and departments of Biomedical Science and Medicine.
As a result, the body does not develop long-term immunity and remains vulnerable to that particular staph infection throughout life. While certain staph bacteria cause mild skin infections, other strains of staph bacteria can wreak havoc in the bloodstream and bones, sometimes leading to amputations.
"The study explains why our immune system is fooled by staph," Martins said. "Staph evolved to have this enzyme that makes this modification in its cell wall. This modification protects the wall from degradation and therefore from being properly detected by the immune system, which won't remember the bacteria the next time the body is infected."
When study authors removed the cell wall modification, the staph cells spilled their molecules more easily. The modified bacteria sparked a robust memory immune response that protected against reinfection.
The study provides clues about what type of element could be added to staph vaccines to make them more effective. Whereas most staph vaccines have tried to stimulate antibodies -- specialized molecules that recognize foreign bodies and help to mobilize the immune system -- this study suggests that a successful vaccine should harness the body's T cells.
Funding for this work was provided by NIH research grants R01AI103542,?R21AI083948 and R01AI127406 and by the F. Widjaja Foundation IBIRI Institute, Cedars-Sinai Medical Center.
Cedars-Sinai is a leader in providing high-quality healthcare encompassing primary care, specialized medicine and research. Since 1902, Cedars-Sinai has evolved to meet the needs of one of the most diverse regions in the nation, setting standards in quality and innovative patient care, research, teaching and community service. Today, Cedars-Sinai is known for its national leadership in transforming healthcare for the benefit of patients. Cedars-Sinai impacts the future of healthcare by developing new approaches to treatment and educating tomorrow's health professionals. Additionally, Cedars-Sinai demonstrates a commitment to the community through programs that improve the health of its most vulnerable residents.
Marni Usheroff | EurekAlert!
Testing corneal cell quality? Apply physics
23.07.2019 | Kyoto University
First impressions go a long way in the immune system
22.07.2019 | Weizmann Institute of Science
Augsburg chemists and physicists report how they have succeeded in the extremely difficult separation of hydrogen and deuterium in a gas mixture.
Thanks to the Surface Acoustic Wave (SAW) technology developed here and already widely used, the University of Augsburg is internationally recognized as the...
Adjusting the thermal conductivity of materials is one of the challenges nanoscience is currently facing. Together with colleagues from the Netherlands and Spain, researchers from the University of Basel have shown that the atomic vibrations that determine heat generation in nanowires can be controlled through the arrangement of atoms alone. The scientists will publish the results shortly in the journal Nano Letters.
In the electronics and computer industry, components are becoming ever smaller and more powerful. However, there are problems with the heat generation. It is...
Scientists have visualised the electronic structure in a microelectronic device for the first time, opening up opportunities for finely-tuned high performance electronic devices.
Physicists from the University of Warwick and the University of Washington have developed a technique to measure the energy and momentum of electrons in...
Scientists at the University Würzburg and University Hospital of Würzburg found that megakaryocytes act as “bouncers” and thus modulate bone marrow niche properties and cell migration dynamics. The study was published in July in the Journal “Haematologica”.
Hematopoiesis is the process of forming blood cells, which occurs predominantly in the bone marrow. The bone marrow produces all types of blood cells: red...
For some phenomena in quantum many-body physics several competing theories exist. But which of them describes a quantum phenomenon best? A team of researchers from the Technical University of Munich (TUM) and Harvard University in the United States has now successfully deployed artificial neural networks for image analysis of quantum systems.
Is that a dog or a cat? Such a classification is a prime example of machine learning: artificial neural networks can be trained to analyze images by looking...
24.06.2019 | Event News
29.04.2019 | Event News
17.04.2019 | Event News
23.07.2019 | Life Sciences
23.07.2019 | Life Sciences
23.07.2019 | Physics and Astronomy